Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Summary
This is a multi-center, randomized, double-blind, double-dummy, placebo/active-controlled study. 200 subjects undergoing abdominal surgery under general anesthesia are planned to be enrolled and randomized into the HSK55718 group, morphine group, and placebo group.
Official title: A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK55718 Injection for Postoperative Pain Treatment in Abdominal Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2026-05-22
Completion Date
2026-11-22
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Interventions
HSK55718 dose level1
Patients administrated with HSK55718 at dose level 1
HSK55718 dose level2
Patients administrated with HSK55718 at dose level 2
HSK55718 dose level 3
Patients administrated with HSK55718 at dose level 3
Placebo control
Patients administrated with placebo
morphine
Patients administrated with morphine
Locations (2)
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China